🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very excited that our #HDAX Therapeutics team is a part of the Lab2Market (#L2M)Toronto Summer 2021 Cohort! Wishing them all the best as they set off on their entrepreneurial journey towards research commercialization! Mitacs #HDAXTx #startup #innovation

Thank you Medicine by Design and HealthInnovationHub for supporting our work at Building a Biotech Venture Pitch Competition, mbd.utoronto.ca/news/hdax-ther…

Thank you Sweet Biopharma Day for amazing sessions today, and honored to have been named 2021 best presentation at this invitation-only life sciences event!

Congratulations to Nabanita Nawar HDAX Therapeutics for winning 2021 Best Presentation at the invitational Sweet Biopharma Day event! #HDAC

Thrilled to be one of the winners of HealthInnovationHub 's Pitch Perfect competition 😀

Amazing pitches and excited to be the winners of the 2021 Therapeutics Focus Award and 2nd Place at #BioTech2021

What better day than #InternationalWomenInScienceDay to announce our 2022 FemSTEM Pitch Competition Finalists? You can register now to join us March 24th as we hear from these cutting edge women-led ventures: bit.ly/3GIFsoe AiimSense HDAX Therapeutics Kultura Diagnostics SciVance

We have been selected for the Emerging Companies Forum at the 18th Annual BIOTECanada Investor Summit. Thank you BIOTECanada and adMare BioInnovations for the exciting opportunity!

Tune in to show your support at the U of T Entrepreneurship Startup Prize pitch competition on March 7th at 2 pm. Visit uoft.me/entweek to register. #UofTStartupPrize

Nabanita Nawar, co-founder of U of T startup HDAX Therapeutics from the Gunning Group pitching at the #UofTStartupPrize pitch competition. #UofTEntWeek

We had a fantastic chat with Donovan Bailey at #UofTEntWeek hosted by University of Toronto Entrepreneurship and excited to be 1st prize winners of the 2022 #UofTStartupPrize pitch competition

H2i's FemSTEM 2022 Pitch Competition is happening on Thursday March 24th from 3:00-5:00 PM EST! To register: bit.ly/3GIFsoe Leading up to the event, we will be introducing you to our six incredible finalists. Meet Nabanita Nawar, PhD, PhD candidate and co-founder of HDAX Therapeutics

On March 24, H2i's FemSTEM series wrapped up with the 2022 Pitch Competition! We would like to congratulate our grand prize winner Rebecca Allan, PhD of SciVance, 1st runner up Nabanita Nawar, PhD of HDAX Therapeutics, and 2nd runner up, Jennifer Doucet of Glusyn Diagnostics! 🥳

Super excited to be selected as an ALPHA startup at Collision Conf! Come check us out at Booth A1102 tomorrow (Tuesday, June 21st 2022) to learn more about how HDAX Therapeutics is designing a targeted therapeutic platform for unmet healthcare needs. #Collision2022

We're excited to announce that HDAX has been chosen to participate in #MassBioDrive fall 2022 cohort!

Immensely proud of HDAX Therapeutics co-founders and Gunning Group alumni Nabanita Nawar, PhD and Pimyupa Manaswiyoungkul for being named among the 2023 Forbes 30 Under 30 Toronto! #ForbesUnder30Local #Forbes30under30 #gunningalumni forbes.com/sites/forbesun…